These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2742312)

  • 1. [Arthropathies following the administration of pefloxacin to an adolescent with mucoviscidosis].
    Kesseler A; Lacassie A; Hugot JP; Talon P; Thomas D; Astier L
    Ann Pediatr (Paris); 1989 Apr; 36(4):275-8. PubMed ID: 2742312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe polyarthropathy in an adolescent treated with pefloxacin.
    Le Loët X; Fessard C; Noblet C; Ait Saït L; Moore N
    J Rheumatol; 1991 Dec; 18(12):1941-2. PubMed ID: 1795342
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparative efficacy and safety of ciprofloxacin, ofloxacin, and pefloxacin in treatment of respiratory infections in children with cystic fibrosis].
    Postnikov SS
    Antibiot Khimioter; 2001; 46(3):16-20. PubMed ID: 11548276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Joint tolerance of pefloxacin and ofloxacin in children and adolescents with cystic fibrosis].
    Pertuiset E; Lenoir G; Jehanne M; Douchain F; Guillot M; Menkès CJ
    Rev Rhum Mal Osteoartic; 1989 Nov; 56(11):735-40. PubMed ID: 2692134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new quinolone (pefloxacine) in bronchopulmonary superinfections in cystic fibrosis].
    Reineri P; Squinazi F; Tobelem R; Lemerle S; Lobut JB; Bernaudin F; Kohout G; Bouveret
    Pediatrie; 1984; 39(7):597-8. PubMed ID: 6598489
    [No Abstract]   [Full Text] [Related]  

  • 6. Azlocillin and gentamicin in respiratory tract infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Malmborg AS; Alfredsson H; Kusoffsky E; Strandvik B
    Scand J Infect Dis Suppl; 1981; 29():64-9. PubMed ID: 6947407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term tobramycin aerosol therapy of chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
    Gappa M; Steinkamp G; Tümmler B; von der Hardt H
    Scand J Gastroenterol Suppl; 1988; 143():74-6. PubMed ID: 3164515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [How should initial colonization by Pseudomonas aeruginosa be treated in patients with cystic fibrosis?].
    David V
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S113-7. PubMed ID: 12910143
    [No Abstract]   [Full Text] [Related]  

  • 9. [Arthropathy caused by pefloxacin. Report of a case. Histologic study of the synovia].
    Ollier S; Laroche M; Arlet P; Montane P; Durroux R; Le Tallec Y
    Rev Rhum Mal Osteoartic; 1990 Oct; 57(9):671. PubMed ID: 2075409
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of destructive polyarthropathy in a 17-year-old youth following pefloxacin treatment.
    Chevalier X; Albengres E; Voisin MC; Tillement JP; Larget-Piet B
    Drug Saf; 1992; 7(4):310-4. PubMed ID: 1524702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ceftazidime treatment of chronic Pseudomonas infection in patients with cystic fibrosis.
    Fluge G; Digranes A; Michalsen H; Stiris T; Bergan T; Qvigstad EK
    Eur J Respir Dis; 1987 Oct; 71(4):239-43. PubMed ID: 3319661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term benefits of inhaled tobramycin in children with cystic fibrosis: first clinical observations from Poland.
    Stelmach I; Korzeniewska A; Stelmach W
    Respiration; 2008; 75(2):178-81. PubMed ID: 17435382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intravenous administration of antibiotics in the treatment of cystic fibrosis].
    Vávrová V; Lochmann O; Suková B; Copová M; Zapletal A; Absolonová V; Houstĕk J
    Cesk Pediatr; 1986 Oct; 41(10):605-7. PubMed ID: 3502950
    [No Abstract]   [Full Text] [Related]  

  • 14. Azlocillin in cystic fibrosis.
    Malmborg AS; Alfredsson H; Strandvik B
    Isr J Med Sci; 1983 Nov; 19(11):1001-3. PubMed ID: 6662681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of quinolones in the treatment of Pseudomonas aeruginosa infections in children with cystic fibrosis].
    Milio MC; Campana S
    Pediatr Med Chir; 1995; 17(1):53-5. PubMed ID: 7739928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pefloxacin: clinical experience].
    Bertrand A; Janbon F; Jourdan J; Jonquet O; Santoni A
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):596-9. PubMed ID: 3937133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategy of antibiotic therapy by various routes of administration in the initial colonization by Pseudomonas aeruginosa].
    Châtain P
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S105-12. PubMed ID: 12910142
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbenicillin in pulmonary infection complicating cystic fibrosis.
    Africa E; Rosenblum H
    Del Med J; 1970 Nov; 42(11):307-8. PubMed ID: 5481955
    [No Abstract]   [Full Text] [Related]  

  • 19. The approach to Pseudomonas aeruginosa in cystic fibrosis.
    Bendiak GN; Ratjen F
    Semin Respir Crit Care Med; 2009 Oct; 30(5):587-95. PubMed ID: 19760546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pulmonary infections in cystic fibrosis: pathogenesis and therapy].
    Götz M
    Monatsschr Kinderheilkd; 1985 Oct; 133(10):718-25. PubMed ID: 3934527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.